Evidence map›Paper›PMID 30154144›Full record

ArticleCancer research2018

PTTG and PBF Functionally Interact with p53 and Predict Overall Survival in Head and Neck Cancer.

Martin L Read, Bhavika Modasia, Alice Fletcher, Rebecca J Thompson, Katie Brookes, Peter C Rae, Hannah R Nieto, Vikki L Poole, Sally Roberts, Moray J Campbell and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. AreFrontiers in endocrinology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Iron, Ferroptosis, and Head and Neck Cancer.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Aspirin Mediates Its Antitumoral Effect Through Inhibiting PTTG1 in Pituitary Adenoma.The Journal of clinical endocrinology and metabolism · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The Oncogenic Roles ofDiagnostics (Basel, Switzerland) · 2020
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Martin L Read *Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom. mccabcjz@bham.ac.uk m.l.read.20@bham.ac.uk.ORCID 0001-8918-4333
Bhavika Modasia *Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
Alice FletcherInstitute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
Rebecca J ThompsonInstitute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
Katie BrookesInstitute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
Peter C RaeInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Hannah R NietoInstitute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
Vikki L PooleInstitute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
Sally RobertsInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.ORCID 0003-4653-9442
Moray J CampbellDivision of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio.
Kristien BoelaertInstitute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
Andrew S TurnellInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Vicki E SmithInstitute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
Hisham MehannaInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.ORCID 0002-5544-6224
Christopher J McCabeInstitute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom. mccabcjz@bham.ac.uk m.l.read.20@bham.ac.uk.ORCID 0002-8687-3405
University of Birmingham · GBCancer Research UK Clinical Trials Unit · GBThe Ohio State University · US

Funding

Medical Research Council MR/P000509/1Wellcome Trust
6 · The paper itself

Abstract

Head and neck squamous cell carcinoma (HNSCC) is the 6th most common cancer worldwide and poses a significant health burden due to its rising incidence. Although the proto-oncogene pituitary tumor-transforming gene 1 (PTTG) predicts poor patient outcome, its mechanisms of action are incompletely understood. We show here that the protein PBF modulates PTTG function, is overexpressed in HNSCC tumors, and correlates with significantly reduced survival. Lentiviral shRNA attenuation of PTTG or PBF expression in HNSCC cells with either wild-type or mutant p53, and with and without HPV infection, led to dysregulated expression of p53 target genes involved in DNA repair and apoptosis. Mechanistically, PTTG and PBF affected each other's interaction with p53 and cooperated to reduce p53 protein stability in HNSCC cells independently of HPV. Depletion of either PTTG or PBF significantly repressed cellular migration and invasion and impaired colony formation in HNSCC cells, implicating both proto-oncogenes in basic mechanisms of tumorigenesis. Patients with HNSCC with high tumoral PBF and PTTG had the poorest overall survival, which reflects a marked impairment of p53-dependent signaling.

Indexed as

Gene Expression Regulation, NeoplasticAdultAgedApoptosisCell Line, TumorCell MovementCell ProliferationCell Transformation, NeoplasticDNA RepairFemaleGene Expression ProfilingHead and Neck NeoplasmsHumansIntracellular Signaling Peptides and ProteinsKaplan-Meier EstimateLentivirusIntracellular Signaling Peptides and ProteinsMAS1 protein, humanMembrane ProteinsNeoplasm Proteinspituitary tumor-transforming protein 1, humanProto-Oncogene MasPTTG1IP protein, humanRNA, Small InterferingSecurinTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID30154144
PMCPMC6193540
OpenAlexW2889341953

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.